Links[{"label":"drugdevelopR.html","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/refman/drugdevelopR.html"},{"label":"drugdevelopR.pdf","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/drugdevelopR.pdf"},{"label":"Bias adjustment - methods for discounting of phase II results","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Bias_adjustment.html"},{"label":"source","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Bias_adjustment.Rmd"},{"label":"R code","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Bias_adjustment.R"},{"label":"Binary outcome variables","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Binary_outcomes.html"},{"label":"source","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Binary_outcomes.Rmd"},{"label":"R code","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Binary_outcomes.R"},{"label":"Fixed effect estimates and prior distributions","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Fixed_and_prior_distributions.html"},{"label":"source","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Fixed_and_prior_distributions.Rmd"},{"label":"R code","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Fixed_and_prior_distributions.R"},{"label":"Interpreting the rest of the output","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Interpreting_Output.html"},{"label":"source","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Interpreting_Output.Rmd"},{"label":"R code","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Interpreting_Output.R"},{"label":"Introduction to planning phase II and phase III trials with drugdevelopR","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Introduction-to-drugdevelopR.html"},{"label":"source","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Introduction-to-drugdevelopR.Rmd"},{"label":"R code","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/Introduction-to-drugdevelopR.R"},{"label":"More parameters to adapt to specific settings","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/More_Parameters.html"},{"label":"source","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/More_Parameters.Rmd"},{"label":"R code","section":"","type":"","url":"https://cran.r-project.org/web/packages/drugdevelopR/vignettes/More_Parameters.R"}]
TextReference manual: drugdevelopR.html , drugdevelopR.pdf Vignettes: Bias adjustment - methods for discounting of phase II results ( source , R code ) Binary outcome variables ( source , R code ) Fixed effect estimates and prior distributions ( source , R code ) Interpreting the rest of the output ( source , R code ) Introduction to planning phase II and phase III trials with drugdevelopR ( source , R code ) More parameters to adapt to specific settings ( source , R code ) Multiarm - methods for multi-arm programs ( source , R code ) Multiple - methods for trials with multiple endpoints ( source , R code ) Multitrial - methods for programs with several phase III trials ( source , R code ) Package validation ( source , R code ) Time-to-event outcome variables ( source , R code )